Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2025-12-25 @ 2:55 PM
Study NCT ID:
NCT02083250
Status:
COMPLETED
Last Update Posted:
2022-01-06
First Post:
2014-03-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-06
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-07
First Submit QC Date:
None
Study First Post Date:
2014-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-15
Last Update Post Date:
2022-01-06
Last Update Post Date Type:
ACTUAL